Pfiz­er CEO un­der fire from UK watch­dog over vac­cine com­ments — re­port

Pfiz­er CEO Al­bert Bourla told the BBC last De­cem­ber that he had “no doubt in my mind that the ben­e­fits, com­plete­ly, are in fa­vor” of vac­ci­nat­ing 5- to 11-year-olds for Covid-19. Al­most a year lat­er, those com­ments have re­port­ed­ly land­ed him in trou­ble with a UK phar­ma watch­dog.

Chil­dren’s ad­vo­ca­cy group Us­ForThem filed a com­plaint with the UK’s Pre­scrip­tion Med­i­cines Code of Prac­tice Au­thor­i­ty (PM­C­PA) last year ac­cus­ing Bourla of mak­ing “dis­grace­ful­ly mis­lead­ing” state­ments dur­ing the BBC in­ter­view, in­clud­ing one that “Covid in schools is thriv­ing.” At the time, UK reg­u­la­tors had not yet cleared the vac­cine for the 5 to 11 age group, though the vac­cine did have a pos­i­tive opin­ion from the EMA’s hu­man med­i­cines com­mit­tee.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER